martes, 12 de noviembre de 2019

Immunotherapies targeting melanoma post strong results, new data show

Immunotherapies targeting melanoma post strong results, new data show

Cancer Briefing

STAT Plus: Immunotherapies targeting melanoma post encouraging results, new data show

By ADAM FEUERSTEIN


ANNE WESTON/FRANCIS CRICK INSTITUTE/WELLCOME
Iovance Biotherapeutics and Nektar Therapeutics presented updates on their melanoma programs at the Society for Immunotherapy of Cancer annual meeting.

No hay comentarios: